Use of cidofovir in pediatric patients with adenovirus infection [version 1; referees: 2 approved]

Background: Adenoviruses contribute to morbidity and mortality among immunocompromised pediatric patients including stem cell and solid organ transplant recipients. Cidofovir (CDV), an antiviral compound approved by the FDA in 1996, is used for treatment of adenoviral (ADV) infections in immunocompr...

Full description

Bibliographic Details
Main Authors: Lakshmi Ganapathi, Alana Arnold, Sarah Jones, Al Patterson, Dionne Graham, Marvin Harper, Ofer Levy
Format: Article
Language:English
Published: F1000 Research Ltd 2016-04-01
Series:F1000Research
Subjects:
Online Access:http://f1000research.com/articles/5-758/v1

Similar Items